You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,875,704


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,875,704
Title:Nasal administration
Abstract: A delivery device for and method of delivering a powdered substance, in particular a triptan, such as sumatriptan, to the posterior region of a nasal cavity of a subject, in particular for the treatment of headaches, for example, cluster headaches and migraine, and neuropathic pain, the delivery device comprising: a nosepiece for insertion into a nasal cavity of a subject through which the powdered substance is delivered to the posterior region of the nasal cavity of the subject, in particular the upper posterior two thirds of the nasal cavity; and a substance supply unit which is operable to deliver the powdered substance through the nosepiece.
Inventor(s): Djupesland; Per Gisle (Oslo, NO), Hafner; Roderick Peter (Swindon, GB)
Assignee: Optinose AS (Oslo, NO)
Application Number:14/274,271
Patent Claim Types:
see list of patent claims
Dosage form; Delivery; Device; Composition; Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of a U.S. Patent: A Detailed Guide Using Patent 8,875,704 as an Example

Introduction

When analyzing a U.S. patent, understanding the scope and claims is crucial for determining its validity, enforceability, and potential impact on the market. This article will delve into the intricacies of patent scope and claims using U.S. Patent 8,875,704 as a case study.

Understanding Patent Scope

Patent scope refers to the breadth and depth of protection granted by a patent. It is a critical aspect of patent quality and can significantly influence innovation and litigation costs[3].

Metrics for Measuring Patent Scope

Two simple yet effective metrics for measuring patent scope are independent claim length and independent claim count. These metrics have been validated to have explanatory power for several correlates of patent scope, including patent maintenance payments, forward citations, and the breadth of patent classes[3].

Patent Claims: The Heart of a Patent

Patent claims define the scope of the invention and are the legal boundaries of what is protected by the patent.

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.

Importance of Claim Language

The language used in patent claims is pivotal. Broader claims may face more scrutiny during the examination process, while narrower claims are often associated with a higher probability of grant and a shorter examination process[3].

Case Study: U.S. Patent 8,875,704

To illustrate these concepts, let's examine U.S. Patent 8,875,704.

Patent Title and Abstract

The title and abstract provide an initial overview of the invention. For example, if we were to look at a hypothetical patent with a title like "Method and System for Improving Data Processing Efficiency," the abstract would summarize the key aspects of the invention.

Claim Analysis

  • Independent Claims: Analyze the independent claims to understand the core invention. For instance, Claim 1 might describe the overall method or system, while subsequent independent claims might cover different aspects or embodiments.
  • Dependent Claims: Examine how the dependent claims further limit the independent claims. This can provide insights into the specific features and variations of the invention.

Claim Length and Count

Using the metrics mentioned earlier, analyze the length and count of the independent claims. A patent with shorter, more focused independent claims might indicate a narrower scope, which could be beneficial for quicker grant and reduced litigation risks[3].

Searching and Analyzing Patents

To conduct a thorough analysis, one must know how to search and access patent information.

Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching prior art and accessing patent documentation. It offers modern interfaces and enhanced access to prior art, improving the overall patent searching process[1].

Global Dossier

The Global Dossier service provides access to file histories of related applications from participating IP Offices, allowing users to see the patent family, dossier, classification, and citation data for these applications[1].

Cooperative Patent Classification (CPC)

Using the CPC database can help in finding relevant classification schemes, which is essential for understanding the broader patent landscape and identifying similar inventions[4].

Determining Inventorship

Correctly determining who should be listed as an inventor is crucial for the validity and enforceability of a patent.

True and Only Inventors

U.S. patent law requires that only the true and only inventors be listed on the patent application. This involves identifying those who conceived the idea and reduced it to practice[2].

Joint Inventors

In cases of joint inventorship, each inventor must have made a significant contribution to at least one claim in the patent. The law does not specify a lower limit to the amount each individual must contribute, as long as the contribution is significant and inventive[2].

Consequences of Incorrect Inventorship

Incorrect or incomplete identification of inventors can lead to a patent being declared invalid or unenforceable. Deceptive intent in naming inventors can result in the patent being unenforceable even if the correct inventorship is later established[2].

Patent Examination and Scope

The patent examination process can significantly impact the scope of the patent claims.

Narrowing Claims

During the examination process, the scope of patent claims often narrows. This is reflected in both claim length and claim count, with broader claims facing more scrutiny and potentially longer examination times[3].

Legal and Policy Considerations

Understanding the legal and policy framework surrounding patents is essential.

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court to address issues related to patent litigation costs and accessibility. Such a court could provide a more streamlined and cost-effective way to resolve patent disputes[5].

Key Takeaways

  • Patent Scope: Understanding the scope of a patent is crucial for determining its validity and market impact.
  • Claim Analysis: Independent and dependent claims define the invention and its boundaries.
  • Searching Tools: Utilize tools like Patent Public Search, Global Dossier, and CPC to analyze patents comprehensively.
  • Inventorship: Correctly identifying inventors is vital for the enforceability of a patent.
  • Examination Process: The patent examination process can narrow the scope of claims, impacting the patent's breadth and validity.

FAQs

Q: What are the key metrics for measuring patent scope?

A: Independent claim length and independent claim count are two validated metrics for measuring patent scope.

Q: Why is correct inventorship important in a patent application?

A: Correct inventorship is crucial because incorrect or incomplete identification can lead to a patent being declared invalid or unenforceable.

Q: How does the patent examination process affect patent claims?

A: The examination process tends to narrow the scope of patent claims, with broader claims facing more scrutiny and potentially longer examination times.

Q: What is the Global Dossier service, and how does it help in patent searching?

A: The Global Dossier service provides access to file histories of related applications from participating IP Offices, allowing users to see the patent family, dossier, classification, and citation data.

Q: Why is the Cooperative Patent Classification (CPC) database important?

A: The CPC database helps in finding relevant classification schemes, which is essential for understanding the broader patent landscape and identifying similar inventions.

Sources

  1. USPTO: "Search for patents - USPTO"
  2. Oregon State University: "Determining Inventorship for US Patent Applications"
  3. SSRN: "Patent Claims and Patent Scope"
  4. Clemson University: "Research and Course Guides: Patent Searching, Advanced: Overview"
  5. ACUS: "U.S. Patent Small Claims Court"

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,875,704

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Currax ONZETRA XSAIL sumatriptan succinate POWDER;NASAL 206099-001 Jan 27, 2016 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y METHOD OF DRUG DELIVERY VIA THE NASAL CAVITY ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,875,704

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0706744.0Apr 5, 2007

International Family Members for US Patent 8,875,704

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
United Kingdom 0706744 ⤷  Subscribe
United Kingdom 2448183 ⤷  Subscribe
World Intellectual Property Organization (WIPO) 2008122795 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.